PURA and NOUV Move Forward With Updated Dividend Plan
May 10 2019 - 10:18AM
InvestorsHub NewsWire
PURA and NOUV Move Forward With
Updated Dividend Plan
Dallas, TX -- May 10, 2019 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) (“PURA”) and Nouveau, Inc. (Nouveau Life Pharmaceuticals
dba Nouveau) (USOTC:
NOUV) (“NOUV”) today confirmed plans to issue a dividend of
NOUV stock to PURA shareholders in conjunction with the spinoff of
PURA’s cannabis cultivation business to NOUV. Next week, the
two companies plan for NOUV to launch a new company website.
The website has been strategically designed to facilitate next
steps in the dividend distribution of NOUV stock to PURA
shareholders.
“As the CEO of PURA and the interim CEO of
NOUV, I can tell you I am pleased with the operational progress of
both companies,” said Brian Shibley. “PURA has recently expanded
its production operations of EVERx CBD Sports Water to include a
second plant and NOUV is moving forward with its first US hemp
crop. Next week PURA will introduce EVERx in South Africa at
the Arnold Sports Festival and NOUV’s making great strides in
carving out its own niche in the legal recreational marijuana
market in Canada.”
To learn more about the two companies
visit:
www.purationinc.com
Disclaimer/Safe
Harbor:
This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any
disease.
Contact:
Puration,
Inc.
Brian
Shibley,
info@aciconglomerated.com
(800)
861-1350
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Apr 2023 to Apr 2024